Department of Biochemistry, Memorial University of Newfoundland, St, John's, NL, A1B 3X9, Canada.
Nutr Metab (Lond). 2014 Jan 17;11(1):6. doi: 10.1186/1743-7075-11-6.
Omega-3 polyunsaturated fatty acids (n-3 PUFA) have been shown to alleviate the symptoms of metabolic disorders, such as heart disease, diabetes, obesity and insulin resistance. Several putative mechanisms by which n-3 PUFA elicit beneficial health effects have been proposed; however, there is still a shortage of knowledge on the proteins and pathways that are regulated by n-3 PUFA.
Using two dimensional polyacrylamide gel electrophoresis (2D-PAGE) and liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis, we investigated the effects of diets high or low in n-3 PUFA on hepatic proteomic profile of C57BL/6 mice.
The findings show for the first time that high dietary n-3 PUFA reduced the expression of regucalcin, adenosine kinase and aldehyde dehydrogenase. On the other hand, diets high in n-3 PUFA increased the expression of apolipoprotein A-I, S-adenosylmethionine synthase, fructose-1, 6-bisphosphatase, ketohexokinase, malate dehydrogenase, GTP-specific succinyl CoA synthase, ornithine aminotransferase and protein disulfide isomerase-A3.
Our findings revealed for the first time that n-3 PUFA causes alterations in several novel functional proteins involved in regulating lipid, carbohydrate, one-carbon, citric acid cycle and protein metabolism, suggesting integrated regulation of metabolic pathways. These novel proteins are potential targets to develop therapeutic strategies against metabolic disorders.
ω-3 多不饱和脂肪酸(n-3PUFA)已被证明可以缓解代谢紊乱的症状,如心脏病、糖尿病、肥胖症和胰岛素抵抗。已经提出了 n-3PUFA 发挥有益健康作用的几种推测机制;然而,对于 n-3PUFA 调节的蛋白质和途径仍然知之甚少。
使用二维聚丙烯酰胺凝胶电泳(2D-PAGE)和液相色谱-串联质谱(LC-MS/MS)分析,我们研究了富含或缺乏 n-3PUFA 的饮食对 C57BL/6 小鼠肝蛋白质组图谱的影响。
研究结果首次表明,高膳食 n-3PUFA 降低了钙调蛋白、腺苷激酶和醛脱氢酶的表达。另一方面,富含 n-3PUFA 的饮食增加了载脂蛋白 A-I、S-腺苷甲硫氨酸合成酶、果糖-1,6-二磷酸酶、酮己糖激酶、苹果酸脱氢酶、GTP 特异性琥珀酰辅酶 A 合成酶、鸟氨酸转氨酶和蛋白二硫键异构酶-A3 的表达。
我们的研究结果首次表明,n-3PUFA 导致参与调节脂质、碳水化合物、一碳、柠檬酸循环和蛋白质代谢的几种新的功能蛋白发生改变,提示代谢途径的综合调节。这些新的蛋白质可能是开发治疗代谢紊乱的治疗策略的潜在靶点。